FDA Approves First And Only Twice-Yearly PrEP Option
It has been a very long journey in the ongoing fight to end the HIV/AIDS epidemic, and now it appears we might be one step closer towards our goal with the FDA approval of Yeztugo.
According to a new report by Gilead Sciences, Yeztugo (lenacapavir) will be the first and so far only option that gives people who need or want PrEP the option of injecting only twice a year.
READ MORE STORIES
- Healing Is A Fluid Journey: How Hurricane Katrina Changed Me
- FEMA Publishes ‘Katrina Declaration’ On Storm’s 20th Anniversary
- Trump All But Admits He’s A Dictator While Threatening Chicago With National Guard Deployment
Take a look below for details on the trials that helped make this advancement possible, via Gilead:
“The FDA approval of Yeztugo, granted under priority review, is supported by data from the Phase 3 PURPOSE 1 trial (NCT04994509) and PURPOSE 2 (NCT04925752) trials conducted by Gilead, part of the most intentionally inclusive HIV prevention clinical trial program ever designed. ≥99.9% of participants who received Yetzugo in PURPOSE 1 and PURPOSE 2 remained HIV negative.”
The unfortunate reality when it comes to PrEP is that it’s being drastically underused. Even with the first PrEP medication being approved over a decade ago in 2012, more than 100 people contracted HIV per day as recently as 2023. And yes, that mainly included the Black population, Hispanic population, women in general and those living in southern America. It’s believed that a twice-yearly PrEP option like Yeztugo can help decrease those stats thanks to its discreet approach and an availability to those with and without insurance coverage.
Head over to Gilead for the full report, and trust that we’ll be keeping our eyes on this advancement that’s being called the “Breakthrough Of 2024.” Here’s to our health!
LIKE US ON FACEBOOK. FOLLOW US ON INSTAGRAM & TWITTER. SUBSCRIBE TO OUR YOUTUBE.
STAY INFORMED! CLICK HERE TO SIGN UP FOR OUR NEWSLETTER!
HEAD TO THE BLACKAMERICAWEB.COM HOMEPAGE
- The 50 Hottest, Flyest & Sexiest Looks from Beyoncé’s ‘Cowboy Carter’ Tour
- Celebs Who Turn 50 This Year
- Urban One Radiothon For St. Jude Kids Raises $1.6 Million
- US Embassy Official Told Trump’s South African Refugee Program Is For White People Only, New Report Says
- Rest In Power: Notable Black Folks Who We’ve Lost In 2025
FDA Approves First And Only Twice-Yearly PrEP Option was originally published on blackamericaweb.com
